Form 8-K Vertex Energy Inc. For: Aug 13
Tweet
Share
E-mail
http://archive.fast-edgar.com/20140814/ADAZB22CJ222K2R2222222Z2GPMFZ2224O62
Filed on: August 14, 2014
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor (NEXPOVIO®) Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress
- As the Lights Fade, Vivid Sydney 2026 Leaves the City Glowing
- Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with previously treated CLL/SLL
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
